Skip to main content
Premium Trial:

Request an Annual Quote

Martin Schmieg, Fredric Rhoads, Peggy Taylor, and Sudhir Agrawal


Sirna Therapeutics said last week that it has named Martin Schmieg as senior vice president and CFO.

Schmieg will direct and oversee Sirna’s financial management, accounting activities, and investor and public relations, and will begin at the company on Sept. 20.

Schmieg was most recently senior vice president and CFO of Advanced Bionics, said Sirna. Prior to this, he was president and CEO of advisory firm MSMTC, and executive vice president at Cytometrics. He holds a BS in business administration from La Salle University and is a CPA.

Pestka Biomedical Laboratories said last week that it has appointed Fredric Rhoads has general manager of the company’s research products group.

Rhoads was most recently vice president of sales and marketing at Ambion, said Pestka.

Signet Laboratories said this week that it has named Peggy Taylor as vice president of production and development.

According to the diagnostics and drug developer, Taylor will assume responsibility for Signet’s GMP facility, its production and development team, and its manufacturing and shipping team.

Taylor most recently was with Sequitur, where she established and headed the company’s research program, Signet said. At Sequitur, Taylor served as vice president of research and vice president of collaborative research, according to Signet.

Taylor holds a PhD in cell biology from Harvard University.

Hybridon said this week that its president and CSO, Sudhir Agrawal, has been named CEO.

Agrawal replaces Stephen Seiler, Hybridon said.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.